A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 2003
Clinical Trial Grant
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Takeda Development Center Americas, Inc
Start Date
April 6, 2026
End Date
December 31, 2030
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Takeda Development Center Americas, Inc
Start Date
April 6, 2026
End Date
December 31, 2030